Biogen's Journey: From Pioneering Success to Stagnation

For George Scangos, the art of decisive leadership is part of his biology, you could say. Scangos is a former lab researcher who rose to the top of the biotech world. Transitioning from a biology researcher at Yale to a pharmaceutical executive, his journey is a testament to the power of interpersonal skills and strategic thinking. As the CEO of Biogen, he transformed the company's performance, leading it to become one of the top performers in the S&P 500 within his first year. In this 2019 conversation, Scangos unveils his approach to tough decision-making and the culture-shaping strategies that drive success. Chief among those strategies: creating space for people to feel comfortable to fail. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.